2015
DOI: 10.17659/01.2015.0064
|View full text |Cite
|
Sign up to set email alerts
|

Huge Bilateral Serous Papillary Cystadenocarcinoma

Abstract: Serous cystadenocarcinoma is one of the common tumors of epithelial origin in ovary. This case report describes a case of 58 year old female who was referred to us with abdominal pain and distension. Subsequent computed tomography and fine needle aspiration cytology revealed bilateral ovarian papillary cystadenocarcioma with omental metastasis. She underwent an laparotomy with complete surgical excision and chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 4 publications
(4 reference statements)
0
3
0
Order By: Relevance
“…Serous papillary cystadenocarcinoma [ 5 ] is one of the most difficult cases in surgical oncology. It is one of the most common ovarian tumors and usually appears at a later stage due to its aggressive nature, the time it takes to identify, and its presentation [ 1 , 2 ]. Serous cystadenocarcinoma appears as a multilocular cystic ovarian neoplasm with papillary projections under the microscope (Figure 4 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Serous papillary cystadenocarcinoma [ 5 ] is one of the most difficult cases in surgical oncology. It is one of the most common ovarian tumors and usually appears at a later stage due to its aggressive nature, the time it takes to identify, and its presentation [ 1 , 2 ]. Serous cystadenocarcinoma appears as a multilocular cystic ovarian neoplasm with papillary projections under the microscope (Figure 4 ).…”
Section: Discussionmentioning
confidence: 99%
“…CA-125 reduction may be used to predict the chemotherapy response in the neoadjuvant environment. Patients who do not respond to CA-125 also do not experience IDS and have a poor prognosis [1][2][3][4][5][6].…”
Section: Figure 4: Histopathological Appearance Of Serous Cystadenoca...mentioning
confidence: 99%
See 1 more Smart Citation